WB analysis of 293 whole cell lysate using GTX81034 CSGALNACT2 antibody, Internal. Loading : 20 microg per lane Dilution : 1:1000
WB analysis of 293 whole cell lysate using GTX81034 CSGALNACT2 antibody, Internal. Loading : 20 microg per lane Dilution : 1:1000
CSGALNACT2 antibody, Internal
GTX81034
Overview
- SupplierGeneTex
- Product NameCSGALNACT2 antibody, Internal
- Delivery Days Customer9
- Application Supplier NoteWB: 1:1000. IHC-P: 1:50-1:100. FACS: 1:10-1:50. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- FormulationLiquid
- Gene ID55454
- Target nameCSGALNACT2
- Target descriptionchondroitin sulfate N-acetylgalactosaminyltransferase 2
- Target synonymsbeta 4 GalNAcT-2; beta4GalNAcT; CHGN2; ChGn-2; chondroitin beta1,4 N-acetylgalactosaminyltransferase 2; chondroitin sulfate N-acetylgalactosaminyltransferase 2; GALNACT2; GALNACT-2; glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase 2; PRO0082
- Protein IDQ8N6G5
- Protein NameChondroitin sulfate N-acetylgalactosaminyltransferase 2
- Scientific DescriptionThis gene encodes a member of the chondroitin N-acetylgalactosaminyltransferase family. The encoded protein is involved in elongation during chondroitin sulfate synthesis. Alternative splicing of this gene results in multiple transcript variants. Two related pseudogenes have been identified on chromosome X. [provided by RefSeq, Feb 2016]
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- CHPF promotes malignancy of breast cancer cells by modifying syndecan-4 and the tumor microenvironment. Liao WC et al., 2021, Am J Cancer ResRead more
- Inflammatory microRNA-194 and -515 attenuate the biosynthesis of chondroitin sulfate during human intervertebral disc degeneration. Hu B et al., 2017 Jul 25, OncotargetRead more